PF-06747143

· Pfizer

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PF-06747143, covering 2019-03-18 to 2019-03-18. Get the full timeline:

Most recent: Clinical Trial Update: A Study Of PF-06747143, As Single Agent Or In Combination With Standard Chemotherapy In Adult Patients With Acute Myeloid Leukemia [Phase 1]

See pricing